Cargando…
The Outcome of Post-Chemotherapy Retroperitoneal Lymph Node Dissection in Patients with Metastatic Bladder Cancer in the Retroperitoneum
PURPOSE: While a definitive cure can be achieved by radical cystectomy and pelvic lymph node dissection in select patients with regional lymphadenopathy, the benefit remains uncertain in patients who present with non-regional metastases. We analyzed the survival outcomes of post-chemotherapy retrope...
Autores principales: | Liu, Nick W., Murray, Katie S., Donat, S. Machele, Herr, Harry W., Bochner, Bernard H., Dalbagni, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401561/ https://www.ncbi.nlm.nih.gov/pubmed/30854412 http://dx.doi.org/10.3233/BLC-180186 |
Ejemplares similares
-
Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063)
por: Dalbagni, Guido, et al.
Publicado: (2017) -
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
por: Hu, Brian, et al.
Publicado: (2018) -
Is ‘second-look’ (re-staging) transurethral resection of bladder tumours a new standard of care?
por: Herr, Harry, et al.
Publicado: (2011) -
Laparoscopic retroperitoneal lymph node dissection for testicular cancer
por: Hillelsohn, Joel H., et al.
Publicado: (2012) -
Retroperitoneal lymph node dissection for germ cell tumour
por: Tran, Vy, et al.
Publicado: (2020)